PRESS RELEASE published on 08/05/2024 at 07:30, 1 year 3 months ago Inside Information / Other news releases Sensorion to participate in Stifel's Biotech Summer Summit 2024 to discuss strategic developments and gene therapy programs for hearing loss disorders Gene Therapy Sensorion Hearing Loss Disorders Stifel Biotech Summer Summit
BRIEF published on 06/27/2024 at 07:35, 1 year 5 months ago Sensorion Announces Appointment of New Chief Financial Officer Chief Financial Officer Biotechnology Sensorion Hearing Loss Laurene Danon
PRESS RELEASE published on 06/27/2024 at 07:30, 1 year 5 months ago Inside Information / Other news releases Sensorion appoints Laurene Danon as Chief Financial Officer, bringing 15 years of experience in investment banking. The company focuses on developing therapies for hearing loss disorders Chief Financial Officer Investment Banking Sensorion Laurene Danon Hearing Loss Therapies
BRIEF published on 05/30/2024 at 07:35, 1 year 6 months ago Sensorion announces the results of its Combined General Meeting Biotechnology Resolutions General Assembly Sensorion Hearing Therapies
BRIEF published on 05/28/2024 at 07:35, 1 year 6 months ago Sensorion Announces Participation in June 2024 Investor Conferences Biotechnology Investor Conferences Healthcare Sensorion Hearing Loss
PRESS RELEASE published on 05/28/2024 at 07:30, 1 year 6 months ago Inside Information / Other news releases Sensorion announces its participation in upcoming investor conferences in June 2024 to present its novel therapies for hearing loss disorders. The company will attend conferences in New York, Miami, and Lyon Biotechnology Investor Conferences June 2024 Sensorion Hearing Loss Disorders
Published on 12/05/2025 at 02:35, 2 hours 46 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 21 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 16 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 21 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 50 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 30 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 55 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 5 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 10 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 21 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 36 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 36 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 20 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
